Profile: Camitro Corporation is a biopharmaceutical company consisting of an integrated platform of predictive models and strategies for the design, selection and optimization of pharmaceutical drug candidates for various ADME properties. The computational models relate compound structure directly to predicted ADME properties, thereby enabling high throughput, in silico design and evaluation of virtual drug candidates throughout the discovery process.